Guillain-Barre Syndrome
Symptoms, Doctors, Treatments, Advances & More

Learn About Guillain-Barre Syndrome

What is the definition of Guillain-Barre Syndrome?

Guillain-Barré syndrome (GBS) is a serious health problem that occurs when the body's defense (immune) system mistakenly attacks part of the peripheral nervous system. This leads to nerve inflammation that causes muscle weakness or paralysis and other symptoms.

What are the alternative names for Guillain-Barre Syndrome?

GBS; Landry-Guillain-Barrésyndrome; Acute idiopathic polyneuritis; Infectious polyneuritis; Acute inflammatory polyneuropathy; Acute inflammatory demyelinating polyradiculoneuropathy; Ascending paralysis; Guillain-Barré syndrome

What are the causes of Guillain-Barre Syndrome?

The exact cause of GBS is unknown. It is thought that GBS is an autoimmune disorder. With an autoimmune disorder, the body's immune system attacks itself by mistake. The incidence of GBS increases with aging, but can occur at any age. People older than 50 years are at the greatest risk.

GBS may occur following infections from viruses or bacteria, such as:

  • Influenza
  • Some gastrointestinal illnesses, especially Campylobacter jejunii infection
  • Mycoplasma pneumonia
  • HIV, the virus that causes HIV/AIDS (very rare)
  • Herpes simplex
  • Mononucleosis
  • COVID-19
  • Zika virus

GBS may also occur with other medical conditions, such as:

  • Systemic lupus erythematosus
  • Hodgkin disease
  • After surgery

GBS damages parts of nerves. This nerve damage causes tingling, muscle weakness, loss of balance, and paralysis. GBS most often affects the nerve covering (myelin sheath). This damage is called demyelination. It causes nerve signals to move more slowly. Damage to other parts of the nerve can cause the nerve to stop working.

What are the symptoms of Guillain-Barre Syndrome?

Symptoms of GBS can get worse quickly. It may take only a few hours for the most severe symptoms to appear. But weakness that increases over several days is also common.

Muscle weakness or loss of muscle function (paralysis) affects both sides of the body. In most cases, the muscle weakness starts in the legs and spreads to the arms. This is called ascending paralysis.

If the inflammation affects the nerves of the chest and diaphragm (the large muscle under your lungs that helps you breathe) and those muscles are weak, you may need breathing assistance.

Other typical signs and symptoms of GBS include:

  • Loss of tendon reflexes in the arms and legs
  • Tingling or numbness (mild loss of sensation)
  • Muscle tenderness or pain (may be a cramp-like pain)
  • Uncoordinated movement (cannot walk without help)
  • Low blood pressure or poor blood pressure control
  • Abnormal heart rate

Other symptoms may include:

  • Blurred vision and double vision
  • Clumsiness and falling
  • Difficulty moving face muscles
  • Feeling your heart beat (palpitations)

Emergency symptoms (seek medical help right away):

  • Cannot take a deep breath
  • Difficulty breathing
  • Difficulty swallowing or choking on food or liquids
  • Drooling
  • Fainting
  • Feeling light headed when standing
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Guillain-Barre Syndrome?

While there is no cure for GBS, most people will notice improvement within days to weeks. Treatment is aimed at reducing symptoms, treating complications, and speeding up recovery.

In the early stages of the illness, a treatment called apheresis or plasmapheresis may be given. It involves removing the proteins, called antibodies, which attack the nerve cells. Another treatment is intravenous immunoglobulin (IVIg). Both treatments lead to faster improvement, and both are equally effective. But there is no advantage to using both treatments at the same time. Other treatments help reduce inflammation.

When symptoms are severe, treatment in the hospital will be needed. Breathing support will likely be given.

Other treatments in the hospital focus on preventing complications. These may include:

  • Blood thinners to prevent blood clots
  • Breathing support or a breathing tube and ventilator, if the diaphragm is weak
  • Pain medicines or other medicines to treat pain
  • Proper body positioning or a feeding tube to prevent choking during feeding, if the muscles used for swallowing are weak
  • Physical therapy to help keep joints and muscles healthy
Who are the top Guillain-Barre Syndrome Local Doctors?
Elite in Guillain-Barre Syndrome
Elite in Guillain-Barre Syndrome

New Jersey Pediatric Neuroscience Institute

385 Prospect Avenue 2nd Floor, 
Hackensack, NJ 
Languages Spoken:
English
Accepting New Patients

Nizar Souayah is a Psychiatrist in Hackensack, New Jersey. Dr. Souayah is rated as an Elite provider by MediFind in the treatment of Guillain-Barre Syndrome. His top areas of expertise are Chronic Inflammatory Demyelinating Polyneuropathy, Guillain-Barre Syndrome, Myasthenia Gravis, and Chronic Polyradiculoneuritis. Dr. Souayah is currently accepting new patients.

Distinguished in Guillain-Barre Syndrome
Distinguished in Guillain-Barre Syndrome

Vanderbilt Medical Group- Teleneurology

1161 21st Ave South, A-0118 Medical Center North, 
Nashville, TN 
Languages Spoken:
English
Offers Telehealth

. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Guillain-Barre Syndrome. His top areas of expertise are Myasthenia Gravis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal Muscular Atrophy (SMA), Guillain-Barre Syndrome, and Gamma Knife Radiosurgery.

 
 
 
 
Learn about our expert tiers
Learn More
James J. Sejvar
Elite in Guillain-Barre Syndrome
Elite in Guillain-Barre Syndrome

UPMC Neurological Institute - Magee

300 Halket Street, Suite 4500, 
Pittsburgh, PA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

James Sejvar, MD, specializes in neurology and is board certified in neurology by the American Board of Psychiatry and Neurology. He practices at University of Pittsburgh Physicians, Department of Neurology and is affiliated with UPMC East and UPMC McKeesport. Dr. Sejvar completed his fellowship at Centers for Disease Control and Prevention, residency at Mayo Clinic School of Graduate Medical Education, and medical education at Geisel School of Medicine at Dartmouth. Dr. Sejvar is rated as an Elite provider by MediFind in the treatment of Guillain-Barre Syndrome. His top areas of expertise are Guillain-Barre Syndrome, Acute Flaccid Myelitis (AFM), Encephalitis, and Zika Virus Disease.

What are the support groups for Guillain-Barre Syndrome?

These resources may provide more information about GBS:

  • GBS/CIDP Foundation International -- www.gbs-cidp.org
  • National Organization for Rare Disorders -- rarediseases.org/rare-diseases/guillain-barre-syndrome
What is the outlook (prognosis) for Guillain-Barre Syndrome?

Recovery can take weeks, months, or years. Most people survive and recover completely. In some people, mild weakness may persist. The outcome is likely to be good when the symptoms go away soon after they first started.

What are the possible complications of Guillain-Barre Syndrome?

Possible complications of GBS include:

  • Breathing difficulty (respiratory failure)
  • Shortening of tissues in the joints (contractures) or other deformities
  • Blood clots (deep vein thrombosis) that form when the person with GBS is inactive or has to stay in bed
  • Increased risk of infections
  • Low or unstable blood pressure
  • Paralysis that is permanent
  • Pneumonia
  • Skin damage (ulcers)
  • Breathing food or fluids into the lungs (aspiration)
When should I contact a medical professional for Guillain-Barre Syndrome?

Seek medical help right away if you have any of these symptoms:

  • Trouble taking a deep breath
  • Decreased feeling (sensation)
  • Difficulty breathing
  • Difficulty swallowing
  • Fainting
  • Loss of strength in the legs that gets worse over time
What are the latest Guillain-Barre Syndrome Clinical Trials?
Phase 2, Randomized, Patient- and Rater-blinded Single-site Trial Evaluating Safety and Efficacy of Efgartigimod in Patients With Guillain-Barré Syndrome.

Summary: The goal of this clinical trial is to evaluate the safety and effectiveness of Efgartigimod in patients with Guillain-Barre syndrome (GBS). The main questions it aims to answer are: * Is Efgartigimod a safe treatment option for GBS patients? * Does treatment with Efgartigimod improve patient outcomes? In addition to standard-of-care procedures and assessments, participants will: * Undergo seven bl...

Match to trials
Find the right clinical trials for you in under a minute
Get started
An Open-Label Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of a Single Dose of Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (GBS) (FORWARD Study)

Summary: The goal of this open label study is to measure pharmacokinetics, pharmacodynamics, early efficacy, and safety of tanruprubart in adult and pediatric participants, in the United States, Canada, and Europe.

Who are the sources who wrote this article ?

Published Date: April 16, 2025
Published By: Joseph V. Campellone, MD, Department of Neurology, Cooper Medical School at Rowan University, Camden, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Bragazzi NL, Kolahi AA, Nejadghaderi SA, et al. Global, regional, and national burden of Guillain-Barré syndrome and its underlying causes from 1990 to 2019. J Neuroinflammation. 2021;18(264). PMID: 34763713 pubmed.ncbi.nlm.nih.gov/34763713/.

Chang CWJ. Myasthenia gravis and Guillain-Barré syndrome. In: Parrillo JE, Dellinger RP, eds. Critical Care Medicine: Principles of Diagnosis and Management in the Adult. 5th ed. Philadelphia, PA: Elsevier; 2019:chap 61.

Katirji B. Disorders of peripheral nerves. In: Jankovic J, Mazziotta JC, Pomeroy SL, Newman NJ, eds. Bradley and Daroff's Neurology in Clinical Practice. 8th ed. Philadelphia, PA: Elsevier; 2022:chap 106.

Smith AG, Shy ME. Peripheral neuropathies. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 388.